Cardiomyocytes deletion of ADAM17 inhibit ACE2 shedding, limit ventricular remodeling, alleviate cardiomyocyte death, restricts scar expansion, and preserve cardiac function post-MI. Here, ACE2 is linked to myocardial infarction.